Consonance Capital Partners (CCP) has announced it will sell Enclara Healthcare to Humana.

Enclara, based in Philadelphia, is a hospice pharmacy benefit manager.

Humana, based in Louisville, Ky., is a national health insurance company.

CCP, based in New York, is a private equity firm targeting companies in the lower middle market of the U.S. healthcare industry. Target companies generally have between $20 million and $150 million in revenues.

Humana will also acquire Enclara Pharmacia, GuidantRx, and Avanti Health Care Services from Consonance as part of the transaction, reports HealthLeaders.

The deal is expected to close during the first half of 2020.